Why Precision BioSciences Shares Are Surging Today

  • Precision BioSciences Inc DTIL has entered into an exclusive worldwide in vivo gene editing research and development collaboration and license agreement with Novartis AG NVS 
  • Precision will develop a custom ARCUS nuclease that will be designed to insert, in vivo, a therapeutic transgene at a "safe harbor" location in the genome as a potential one-time transformative treatment option for sickle cell disease and beta-thalassemia.
  • Under the terms of the Agreement, Precision will develop an ARCUS nuclease and conduct in vitro characterization, with Novartis then assuming responsibility for all subsequent research, development, manufacturing, and commercialization activities. 
  • Precision will receive an upfront payment of $75 million and is eligible to receive up to $1.4 billion in additional payments for future milestones. 
  • Upon completion of the transaction, Precision expects that existing cash and equivalents, expected operational receipts, and available credit will be sufficient to fund its operating expenses and capital expenditure requirements into Q2 2024.
  • Precision BioSciences has announced a common stock offering of 35.9 million shares at $1.39/share, for approximately $50.0 million in gross proceeds
  • Price Action: DTIL shares are up 12.23% at $1.56 during the premarket session on the last check Wednesday.

Posted In: Briefswhy it's movingBiotechLarge CapNewsPenny StocksHealth CareFinancingContractsMoversTrading IdeasGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.